Influenza - Pipeline Review, Q1 2011

Global Markets Direct
February 28, 2011
131 Pages - SKU: GMD6185846
2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
1/12/2015 | published by: VPGMarketResearch.com
2015 European Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing This new 970-page comprehensive five-country report from VPGMarketResearch.com is designed to help current  |  read more...
USD 19,700
Epigenetic Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Epigenetic abnormalities are frequent events implicated in the development of many different types of tumors. The first epigenetic modification that was linked to cancer was methylation and to date there are several approved epigenetic drugs  |  read more...
USD 4,496
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four  |  read more...
USD 6,746
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the cell-extracellular matrix contact points, specialized structures are formed and termed  |  read more...
USD 6,746
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
There are today 173 companies plus partners developing 171 metabolic pathways targeting drugs in 478 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the  |  read more...
USD 6,746
Liver Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
There are today 183 companies plus partners developing 219 drugs targeting liver cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to  |  read more...
USD 4,496
Fierce 15 in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
The prestigious Fierce 15 biotech award has come to symbolize novelty and being at the forefront of biotechnology development amongst privately held businesses. The winners of this award are aiming at breakthroughs and big things,  |  read more...
USD 4,478
Gene Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
There are today 122 companies plus partners developing 100 gene therapy drugs in 280 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last  |  read more...
USD 6,746
Hematological Cancers Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity. There are today 485 companies plus partners developing 752 hematological cancer drugs in 1767 developmental projects  |  read more...
USD 8,996
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. The hypoxia-inducible factors (HIFs) are a  |  read more...
USD 6,746
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!